Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : November 2025

Delivery Time : 2-3 Business Days

Purchase This Report

Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Global Market Report 2025

Name: Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product Type (Lipid Nanoparticle Formulations, Polymer-Based Formulations, Lyophilized Messenger Ribonucleic Acid (mRNA) Vials, Others Product Types), By Distribution Channel (Direct Sales, Distributors, Online Sales, Others Distribution Channels), By Application (Vaccines, Therapeutics, Research, Others Applications), By End User (Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Others End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

• Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial market size has reached to $1.77 billion in 2024

• Expected to grow to $3.33 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%

• Growth Driver: Surge In Global Vaccination Participation Driving The Growth Of The Market Due To Easier Distribution And Wider Accessibility

• Market Trend: Companies Focus On Innovation To Enhance Manufacturing Efficiency And Global Accessibility

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?

A temperature-stable messenger ribonucleic acid (mRNA) vial is a specially designed container that maintains the integrity and effectiveness of mRNA formulations without requiring ultra-cold storage. It uses advanced stabilization technologies to protect the sensitive mRNA molecules from degradation at higher temperatures, allowing for easier handling, wider distribution, and more reliable use of mRNA-based products.

The main product types of temperature-stable messenger ribonucleic acid (mRNA) vials include lipid nanoparticle formulations, polymer-based formulations, lyophilized messenger ribonucleic acid (mRNA) vials, and others. Lipid nanoparticle formulations are delivery systems that encapsulate and protect messenger RNA molecules for efficient cellular uptake. It is distributed through direct sales, distributors, online sales, and others and is applied for vaccines, therapeutics, research, and others. It is used by several end users, including hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and others.

Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Size and growth rate 2025 to 2029: Graph

What Is The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Growth Forecast?

The temperature-stable messenger ribonucleic acid (mRNA) vial market size is expected to see rapid growth in the next few years. It will grow to $3.33 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing demand for temperature-stable formulations, growing focus on reducing cold chain costs, rising adoption of mrna in oncology, expansion of global immunization initiatives, and increasing investments in biopharmaceutical research and development (r&d). Major trends in the forecast period include technology advancements in formulation science, innovations in cold chain free delivery, developments in lyophilized messenger ribonucleic acid (mRNA) vials, research and developments in stability testing, and digitalization of supply chain monitoring.

What Is The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Size 2025 And Growth Rate?

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Segmented?

1) By Product Type: Lipid Nanoparticle Formulations, Polymer-Based Formulations, Lyophilized Messenger Ribonucleic Acid (mRNA) Vials, Others Product Types

2) By Distribution Channel: Direct Sales, Distributors, Online Sales, Others Distribution Channels

3) By Application: Vaccines, Therapeutics, Research, Others Applications

4) By End User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Others End Users

Subsegments:

1) By Lipid Nanoparticle Formulations: Cationic Lipid Nanoparticles, Ionizable Lipid Nanoparticles, Neutral Lipid Nanoparticles

2) By Polymer-Based Formulations: Polyethylene Glycol-Based Formulations, Polymeric Micelles, Dendrimer-Based Formulations

3) By Lyophilized Messenger Ribonucleic Acid Vials: Single-Dose Vials, Multi-Dose Vials

4) By Others Product Types: Peptide-Based Formulations, Protein-Based Formulations, Hybrid Formulations

What Is Driving The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market? Surge In Global Vaccination Participation Driving The Growth Of The Market Due To Easier Distribution And Wider Accessibility

The increasing participation in global vaccination is expected to propel the growth of the temperature-stable messenger ribonucleic acid (mRNA) vial market going forward. A vaccine is a substance designed to trigger the body’s immune response, helping it build protection against a particular disease. The rise in global vaccine participation is driven by international collaboration, as coordinated efforts between countries ensure wider access and equitable distribution of vaccines. Temperature-stable mRNA vials support global vaccination by enabling easier storage, transportation, and distribution across diverse regions without reliance on complex cold chain systems, thereby ensuring wider accessibility and sustained immunization coverage worldwide. For instance, in October 2025, according to Gavi, a US-based international organization that provides vaccines to children in developing countries, DTP3 vaccine coverage in Gavi-supported lower-income countries increased to 82%, up from 80% in 2023, nearing pre-pandemic levels. Therefore, the increasing participation in global vaccination is driving the growth of the temperature-stable messenger ribonucleic acid (mRNA) vial market.

Who Are The Major Players In The Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?

Major companies operating in the temperature-stable messenger ribonucleic acid (mrna) vial market are Arcturus Therapeutics Holdings Inc., CureVac AG, Sanofi S.A., Lonza Group AG, Gerresheimer AG, Stevanato Group, Schott AG, CSafe Global, Gennova Biopharmaceuticals Ltd., TTP Group, Peli BioThermal LLC, SiO2 Materials Science, Shijiazhuang Xinfuda Medical Packaging, Vaxess Technologies, Ethris, Lyophilization Techniques, 20Med Therapeutics BV, EnsiliTech, HDT Bio Corp., and Emervax.

What Are The Key Trends Of The Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market? Companies Focus On Innovation To Enhance Manufacturing Efficiency And Global Accessibility

Major companies operating in the temperature-stable messenger ribonucleic acid (mRNA) vial market are focusing on developing innovative approaches, such as technology transfer models, to enhance manufacturing efficiency, expand global production capacity, and improve accessibility of vaccines in low- and middle-income countries. Technology transfer models refer to processes for sharing knowledge, skills, and manufacturing techniques from one organization to another to enable local production and wider distribution. For instance, in January 2024, SCHOTT Pharma, a Germany-based pharmaceutical packaging company, launched the EVERIC freeze vials. EVERIC freeze vials withstand temperatures as low as -80°C, making them suitable for vaccines and drugs such as mRNA and gene therapy treatments used for infectious diseases, cancer, and central nervous system disorders. Their strength-optimized design reduces the risk of breakage, preventing loss of life-saving medications and costly downtimes.

Need data on a specific region in this market?

Request Customisation

What Are Latest Mergers And Acquisitions In The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market? 20Med Equipment Solutions And CEPI Partner To Advance Temperature-Stable mRNA Vaccine Technology

In February 2023, 20med equipment solutions private limited, a Netherlands-based company provides digital transformation services and a B2B marketplace for healthcare businesses, partnered with Coalition for Epidemic Preparedness Innovations (CEPI) to develop RNA and DNA vaccines and therapeutics. Through this partnership, CEPI and 20Med seek to advance bio-responsive nanoparticle technology to eliminate the need for frozen storage of mRNA vaccines and improve global vaccine accessibility. Coalition for Epidemic Preparedness Innovations (CEPI) a Norway-based supports innovations like temperature-stable mRNA vials to improve vaccine storage, distribution, and accessibility worldwide.

What Is The Regional Outlook For The Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?

North America was the largest region in the temperature-stable messenger ribonucleic acid (mRNA) vial market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the temperature-stable messenger ribonucleic acid (mRNA) vial market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the temperature-stable messenger ribonucleic acid (mRNA) vial market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?

The temperature-stable messenger ribonucleic acid (mRNA) vial consists of sales of stoppers, seals, caps, labels, and packaging materials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Industry?

The temperature-stable messenger ribonucleic acid (mRNA) vial market research report is one of a series of new reports from The Business Research Company that provides temperature-stable messenger ribonucleic acid (mRNA) vial market statistics, including temperature-stable messenger ribonucleic acid (mRNA) vial industry global market size, regional shares, competitors with a temperature-stable messenger ribonucleic acid (mRNA) vial market share, detailed temperature-stable messenger ribonucleic acid (mRNA) vial market segments, market trends and opportunities, and any further data you may need to thrive in the temperature-stable messenger ribonucleic acid (mRNA) vial industry. This temperature-stable messenger ribonucleic acid (mRNA) vial market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

1. Executive Summary

2. Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Characteristics

3. Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Trends And Strategies

4. Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Growth Analysis And Strategic Analysis Framework

5.1. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Growth Rate Analysis

5.4. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Total Addressable Market (TAM)

6. Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Segmentation

6.1. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lipid Nanoparticle Formulations

Polymer-Based Formulations

Lyophilized Messenger Ribonucleic Acid (mRNA) Vials

Others Product Types

6.2. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Direct Sales

Distributors

Online Sales

Others Distribution Channels

6.3. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vaccines

Therapeutics

Research

Others Applications

6.4. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Research Institutes

Pharmaceutical & Biotechnology Companies

Others End Users

6.5. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Sub-Segmentation Of Lipid Nanoparticle Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cationic Lipid Nanoparticles

Ionizable Lipid Nanoparticles

Neutral Lipid Nanoparticles

6.6. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Sub-Segmentation Of Polymer-Based Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polyethylene Glycol-Based Formulations

Polymeric Micelles

Dendrimer-Based Formulations

6.7. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Sub-Segmentation Of Lyophilized Messenger Ribonucleic Acid Vials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single-Dose Vials

Multi-Dose Vials

6.8. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Sub-Segmentation Of Others Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Peptide-Based Formulations

Protein-Based Formulations

Hybrid Formulations

7. Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Regional And Country Analysis

7.1. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

8.1. Asia-Pacific Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

9.1. China Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

9.2. China Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

10.1. India Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

11.1. Japan Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

11.2. Japan Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

12.1. Australia Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

13.1. Indonesia Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

14.1. South Korea Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

14.2. South Korea Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

15.1. Western Europe Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

15.2. Western Europe Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

16.1. UK Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

17.1. Germany Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

18.1. France Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

19.1. Italy Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

20.1. Spain Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

21.1. Eastern Europe Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

21.2. Eastern Europe Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

22.1. Russia Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

23.1. North America Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

23.2. North America Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

24.1. USA Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

24.2. USA Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

25.1. Canada Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

25.2. Canada Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

26.1. South America Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

26.2. South America Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

27.1. Brazil Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

28.1. Middle East Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

28.2. Middle East Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

29.1. Africa Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

29.2. Africa Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Competitive Landscape And Company Profiles

30.1. Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Competitive Landscape

30.2. Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Company Profiles

30.2.1. Arcturus Therapeutics Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. CureVac AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis

31. Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Other Major And Innovative Companies

31.1. Stevanato Group

31.2. Schott AG

31.3. CSafe Global

31.4. Gennova Biopharmaceuticals Ltd.

31.5. TTP Group

31.6. Peli BioThermal LLC

31.7. SiO2 Materials Science

31.8. Shijiazhuang Xinfuda Medical Packaging

31.9. Vaxess Technologies

31.10. Ethris

31.11. Lyophilization Techniques

31.12. 20Med Therapeutics BV

31.13. EnsiliTech

31.14. HDT Bio Corp.

31.15. Emervax

32. Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

34. Recent Developments In The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

35. Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market High Potential Countries, Segments and Strategies

35.1 Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market In 2029 - Countries Offering Most New Opportunities

35.2 Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market In 2029 - Segments Offering Most New Opportunities

35.3 Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Sub-Segmentation Of Lipid Nanoparticle Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Sub-Segmentation Of Polymer-Based Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Sub-Segmentation Of Lyophilized Messenger Ribonucleic Acid Vials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Sub-Segmentation Of Others Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Arcturus Therapeutics Holdings Inc. Financial Performance

Table 80: CureVac AG Financial Performance

Table 81: Sanofi S.A. Financial Performance

Table 82: Lonza Group AG Financial Performance

Table 83: Gerresheimer AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Sub-Segmentation Of Lipid Nanoparticle Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Sub-Segmentation Of Polymer-Based Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Sub-Segmentation Of Lyophilized Messenger Ribonucleic Acid Vials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Sub-Segmentation Of Others Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Arcturus Therapeutics Holdings Inc. Financial Performance

Figure 80: CureVac AG Financial Performance

Figure 81: Sanofi S.A. Financial Performance

Figure 82: Lonza Group AG Financial Performance

Figure 83: Gerresheimer AG Financial Performance

Strategic Growth Drivers Shaping the Nutraceutical Excipients Market Outlook 2025- 2034:The Role Of Health And Wellness In Driving Growth In The Nutraceutical Excipients Market

Emerging Growth Drivers in the Opioids Market Landscape: Growing Surgical Procedures Fueling Demand In The Opioids Market

Osimertinib Drugs Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Otic Drugs Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Active Data Warehousing (ADW) Global Market Report 2025 – By Deployment Mode (Cloud-Based, On-Premises), By Enterprise Size (Large Enterprise, Small And Medium-Sized Enterprise), By Industry Vertical (Banking, Financial ...

View Report

External Ventricular Drain Global Market Report 2025 – By Product (External Ventricular Drainage Set, Accessories), By Application (Traumatic Brain Injury, Intracranial Hemorrhage, Hydrocephalus, Other Applications), By ...

View Report

Progressive Multifocal Leukoencephalopathy Treatment Global Market Report 2025 – By Treatment (Anti-retroviral Therapy, Antiviral Or Anti-John Cunningham Virus (JCV), Other Symptomatic), By Indication (HIV Or AIDS, Organ...

View Report

Hidradenitis Suppurativa Global Market Report 2025 – By Skin Condition (Folliculitis, Pimples, Boils, Deep-Acne), By Product (Tablet, Intravenous (IV) Injection), By Route Of Administration (Oral, Parenteral), By Treatme...

View Report

Optogenetics Global Market Report 2025 – By Product (Lasers, Actuators, Sensors), By Application (Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications), By End User (Hospitals And Clinics, Dia...

View Report

Rubber Process Oil Global Market Report 2025 – By Type (Aromatic, Paraffinic, Naphthenic, Mild Extracted Solvent (MES), Residual Aromatic Extracted Solvent (RAE), Treated Distillate Aromatic Extracted Solvent (TDAE)), By...

View Report

Frequently Asked Questions

What is the definition of the Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial market?

How will the Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial market drivers and restraints affect the market dynamics? What forces will shape the Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial industry going forward?

The market major growth driver - Surge In Global Vaccination Participation Driving The Growth Of The Market Due To Easier Distribution And Wider Accessibility. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial market?

The temperature-stable messenger ribonucleic acid (mRNA) vial market size has grown rapidly in recent years. It will grow from $1.77 billion in 2024 to $2.01 billion in 2025 at a compound annual growth rate (CAGR) of 13.8%. The growth in the historic period can be attributed to increasing demand for cold chain logistics, growing adoption of mrna vaccines, rising government funding for vaccine storage, expansion of global vaccination programs, and increasing clinical trials for infectious diseases. The temperature-stable messenger ribonucleic acid (mRNA) vial market size is expected to see rapid growth in the next few years. It will grow to $3.33 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing demand for temperature-stable formulations, growing focus on reducing cold chain costs, rising adoption of mrna in oncology, expansion of global immunization initiatives, and increasing investments in biopharmaceutical research and development (r&d). Major trends in the forecast period include technology advancements in formulation science, innovations in cold chain free delivery, developments in lyophilized messenger ribonucleic acid (mRNA) vials, research and developments in stability testing, and digitalization of supply chain monitoring. For further insights on this market, request a sample here

How is the Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial market segmented?

The temperature-stable messenger ribonucleic acid (mrna) vialmarket covered in this report is segmented –
1) By Product Type: Lipid Nanoparticle Formulations, Polymer-Based Formulations, Lyophilized Messenger Ribonucleic Acid (mRNA) Vials, Others Product Types
2) By Distribution Channel: Direct Sales, Distributors, Online Sales, Others Distribution Channels
3) By Application: Vaccines, Therapeutics, Research, Others Applications
4) By End User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Others End Users Subsegments:
1) By Lipid Nanoparticle Formulations: Cationic Lipid Nanoparticles, Ionizable Lipid Nanoparticles, Neutral Lipid Nanoparticles
2) By Polymer-Based Formulations: Polyethylene Glycol-Based Formulations, Polymeric Micelles, Dendrimer-Based Formulations
3) By Lyophilized Messenger Ribonucleic Acid Vials: Single-Dose Vials, Multi-Dose Vials
4) By Others Product Types: Peptide-Based Formulations, Protein-Based Formulations, Hybrid Formulations For further insights on this market, request a sample here

Which region has the largest share of the Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial market? What are the other regions covered in the report?

Who are the major players in the Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial market?

What are the key trends in the Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial market?

Major trends in this market include Companies Focus On Innovation To Enhance Manufacturing Efficiency And Global Accessibility. For further insights on this market, request a sample here.

Book your 30 minutes free consultation with our research experts

Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Global Market Report 2025

Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

What Is Covered Under Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?

What Is The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Growth Forecast?

What Is The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Size 2025 And Growth Rate?

What’s The Trade War Impact On Pharmaceuticals Industry?

How Is The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Segmented?

What Is Driving The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market? Surge In Global Vaccination Participation Driving The Growth Of The Market Due To Easier Distribution And Wider Accessibility

Who Are The Major Players In The Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?

What Are The Key Trends Of The Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market? Companies Focus On Innovation To Enhance Manufacturing Efficiency And Global Accessibility

What Are Latest Mergers And Acquisitions In The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market? 20Med Equipment Solutions And CEPI Partner To Advance Temperature-Stable mRNA Vaccine Technology

What Is The Regional Outlook For The Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?

What Defines the Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Industry?

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions